SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-080672
Filing Date
2022-12-19
Accepted
2022-12-19 08:00:24
Documents
1
Period of Report
2022-12-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3753
  Complete submission text file 0001213900-22-080672.txt   5099
Mailing Address C/O CORONADO BIOSCIENCES, INC. 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address
Weisman Harlan F (Reporting) CIK: 0001555563 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39102 | Film No.: 221469639

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Issuer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations